Published in J Am Coll Cardiol on April 01, 1993
Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet (2006) 2.34
Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag (2005) 2.15
Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol (2006) 1.72
The vascular endothelium and human diseases. Int J Biol Sci (2013) 1.49
High-salt diet and hypertension: focus on the renin-angiotensin system. Kidney Blood Press Res (2010) 1.04
Human endothelial dysfunction: EDRFs. Pflugers Arch (2010) 1.04
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease. Heart (2005) 1.01
Endothelial effects of antihypertensive treatment: focus on irbesartan. Vasc Health Risk Manag (2008) 0.99
Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials. PLoS One (2014) 0.94
Sympathetic activation and nitric oxide function in early hypertension. Am J Physiol Heart Circ Physiol (2012) 0.93
Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol (2009) 0.82
Modular prevention of heart disease following acute coronary syndrome (ACS) [ISRCTN42984084]. BMC Cardiovasc Disord (2006) 0.81
Reversible suppression of nitric oxide system in essential hypertension. Indian J Clin Biochem (2003) 0.80
Improvement of endothelial function by amlodipine and vitamin C in essential hypertension. Korean J Intern Med (2002) 0.77
Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol. J Clin Hypertens (Greenwich) (2015) 0.75
Impairement of endothelium-dependent relaxation in chronic two-kidney, one clip hypertensive rats. Korean J Intern Med (1994) 0.75
Attenuation of contractile responses to sympathetic co-transmitters in veins from subjects with essential hypertension. Clin Auton Res (1997) 0.75
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med (1990) 5.91
Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (1994) 4.94
Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95
Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med (1991) 3.80
Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med (1996) 3.40
Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation (1973) 3.31
Colitis cystica profunda. Am J Clin Pathol (1966) 3.28
Sudden death in young athletes. Circulation (1980) 3.05
Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med (1977) 2.94
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med (1987) 2.88
Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med (1994) 2.80
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol (2000) 2.61
Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation (1989) 2.56
"Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol (1988) 2.53
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. N Engl J Med (1989) 2.45
Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol (1981) 2.37
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res (2001) 2.33
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Comparative left ventricular dimensions in trained athletes. Ann Intern Med (1975) 2.27
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol (2001) 2.22
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2). N Engl J Med (1987) 2.18
Ischemia during ambulatory monitoring as a prognostic indicator in patients with stable coronary artery disease. JAMA (1997) 2.17
Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation (1976) 2.08
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol (2000) 2.05
Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation (1981) 2.00
Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation (1994) 1.98
Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.96
Operative treatment in hypertrophic subaortic stenosis. Techniques, and the results of pre and postoperative assessments in 83 patients. Circulation (1975) 1.96
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation (1993) 1.90
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol (1981) 1.89
Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris. Circulation (1971) 1.89
Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1993) 1.89
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation (1982) 1.87
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings. Circulation (1974) 1.85
Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. N Engl J Med (1966) 1.83
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation (1985) 1.81
Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation (1993) 1.81
Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation (1979) 1.80
Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. Am J Cardiol (1978) 1.78
"Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol (1978) 1.76
Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation (1994) 1.66
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis (2000) 1.66
Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation (1994) 1.65
Endothelial progenitor cells as putative targets for angiostatin. Cancer Res (1999) 1.63
Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol (1979) 1.63
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation (1992) 1.63
Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1967) 1.61
Limitations of the electrocardiographic response to exercise in predicting coronary-artery disease. N Engl J Med (1975) 1.61
Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation (2001) 1.61
Role of nitric oxide in the vasodilator response to mental stress in normal subjects. Am J Cardiol (1997) 1.61
Morphology of ambulatory ST segment changes in patients with varying severity of coronary artery disease. Investigation of the frequency of nocturnal ischaemia and coronary spasm. Br Heart J (1985) 1.58
Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol (1987) 1.57
Inability of the ST segment/heart rate slope to predict accurately the severity of coronary artery disease. Br Heart J (1984) 1.56
Asymetric septal hypertrophy in childhood. Circulation (1976) 1.56
Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. J Clin Invest (1969) 1.56
Asymmetric septal hypertrophy (ASH): the unifying link in the IHSS disease spectrum. Observations regarding its pathogenesis, pathophysiology, and course. Circulation (1973) 1.55
Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. J Am Coll Cardiol (1992) 1.55
Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol (1979) 1.55
Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina. A clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation (1993) 1.54
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. Circulation (1984) 1.54
Echocardiographic measurement of the left ventricular outflow gradient in idiopathic hypertrophic subaortic stenosis. N Engl J Med (1973) 1.52
Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol. J Am Coll Cardiol (1991) 1.52
Exercise-induced ischemia in mildly symptomatic patients with coronary-artery disease and preserved left ventricular function. Identification of subgroups at risk of death during medical therapy. N Engl J Med (1984) 1.51
Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res (1993) 1.51
Sudden cardiac death without warning. Possible mechanisms and implications for screening asymptomatic populations. N Engl J Med (1989) 1.50
Measurement of mitral orifice area in patients with mitral valve disease by real-time, two-dimensional echocardiography. Circulation (1975) 1.49
Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol (2000) 1.48
Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris. Am J Cardiol (1981) 1.45
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation (1994) 1.45
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet (1996) 1.44
Incidence of spasm at the site of previous successful transluminal coronary angioplasty: effect of ergometrine maleate in consecutive patients. Br Heart J (1986) 1.43
Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. N Engl J Med (1969) 1.43
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42
Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. Am J Cardiol (1980) 1.42
Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study. J Am Coll Cardiol (1993) 1.42
Natural history of left ventricular function during 1 year after acute myocardial infarction: comparison with clinical, electrocardiographic and biochemical determinations. Am J Cardiol (1980) 1.42
Comparison of echocardiographic and necropsy measurements of ventricular wall thicknesses in patients with and without disproportionate septal thickening. Circulation (1977) 1.41
Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease. Lancet (1984) 1.41
Current concepts: evaluation of patients after acute myocardial infarction: indications for cardiac catheterization and surgical intervention. N Engl J Med (1982) 1.41
Sensitivity, specificity and predictive accuracy of radionuclide cineangiography during exercise in patients with coronary artery disease. Comparison with exercise electrocardiography. Circulation (1979) 1.40
Circulatory and symptomatic effects of physical training in patients with coronary-artery disease and angina pectoris. N Engl J Med (1972) 1.40
Acute vascular effects of estrogen in postmenopausal women. Circulation (1994) 1.39
Serial long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function. Circulation (1991) 1.39
Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension (1997) 1.38